Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.35 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28063817 | 0.97 | PPARD (0.44) | PPARDFDPSKDM4EMMP2THRB | |
| SCHEMBL1131657 | 0.88 | FDPS (0.50) | PPARDFDPSKDM4EMMP2THRB | |
| SCHEMBL19169487 | 0.88 | FDPS (0.50) | PPARDFDPSKDM4EMMP2THRB | |
| SCHEMBL28299764 | 0.85 | PPARD (0.41) | PPARDFDPSKDM4EMMP2THRB | |
| SCHEMBL18097921 | 0.84 | PPARD (0.37) | PPARDMMP2 | |
| SCHEMBL8529848 | 0.83 | PPARD (0.39) | PPARDFDPSKDM4EMMP2THRB | |
| SCHEMBL1661755 | 0.81 | — | — | |
| SCHEMBL12259745 | 0.81 | FDPS (0.43) | PPARDFDPSBLMTDP1 | |
| Hydrochloric Acid SCHEMBL3549676 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL3955404 | 0.79 | PPARD (0.58) | PPARDTDP1TSHRCA2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230323087-A1 | Antimony Trioxide Free Flame Retardant Polymer Composition | LANXESS CORPORATION (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230323087-A1 | Antimony Trioxide Free Flame Retardant Polymer Composition | LANXESS CORPORATION (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230227628-A1 | Flame retardant and stabilizer combined for use with thermoplastics | LANXESS CORPORATION (US) | 2023-07-20 | — | — | US | disclosed |
| US-20230227630-A1 | Flame Retardant and Stabilizer Combined for Use with Thermoplastics | LANXESS CORPORATION (US) | 2023-07-20 | — | — | US | disclosed |
| US-20230227630-A1 | Flame Retardant and Stabilizer Combined for Use with Thermoplastics | LANXESS CORPORATION (US) | 2023-07-20 | — | — | US | disclosed |
| US-20230227628-A1 | Flame retardant and stabilizer combined for use with thermoplastics | LANXESS CORPORATION (US) | 2023-07-20 | — | — | US | disclosed |
| US-20220073547-A1 | Method of Preparing Phosphorus-Containing Flame Retardants and Their Use in Polymer Compositions | LANXESS CORPORATION (US) | 2022-03-10 | — | — | US | disclosed |
| WO-2021257755-A1 | ANTIMONY TRIOXIDE FREE FLAME RETARDANT POLYMER COMPOSITION | LANXESS CORPORATION (US) | 2021-12-23 | — | — | WO | disclosed |
| WO-2021257749-A2 | FLAME RETARDANT AND STABILIZER COMBINED FOR USE WITH THERMOPLASTICS | LANXESS CORPORATION (US) | 2021-12-23 | — | — | WO | disclosed |
| WO-2021257756-A1 | FLAME RETARDANT AND STABILIZER COMBINED FOR USE WITH THERMOPLASTICS | LANXESS CORPORATION (US) | 2021-12-23 | — | — | WO | disclosed |
| EP-0689558-A1 | PHOSPHORUS-MODIFIED EPOXY RESINS, PROCESS FOR PRODUCING THEM AND THEIR USE | SIEMENS AKTIENGESELLSCHAFT (DE) | 1996-01-03 | — | — | EP | disclosed |
| WO-1995029682-A1 | BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWIS?a¿ | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1995-11-09 | — | — | WO | disclosed |
| US-5444050-A | Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1995-08-22 | — | — | US | disclosed |
| EP-0650972-A1 | Process for the preparation of alkanephosphonic acid anhydrides | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-05-03 | — | — | EP | disclosed |
| WO-1994021703-A1 | EPOXY RESIN MIXTURES | SIEMENS AKTIENGESELLSCHAFT (DE) | 1994-09-29 | — | — | WO | disclosed |
| WO-1994021704-A1 | PHOSPHORUS-MODIFIED EPOXY RESINS, PROCESS FOR PRODUCING THEM AND THEIR USE | SIEMENS AKTIENGESELLSCHAFT (DE) | 1994-09-29 | — | — | WO | disclosed |
| US-5347029-A | Dialkyl (dialkoxyphosphinyl)methyl phosphates as anti-inflammatory agents | THE UPJOHN COMPANY (US) | 1994-09-13 | — | — | US | disclosed |
| EP-0590009-A1 | DIALKYL (DIALKOXYPHOSPHINYL)METHYL PHOSPHATES AS ANTI-INFLAMMATORY AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 1994-04-06 | — | — | EP | disclosed |
| WO-1992022559-A1 | DIALKYL (DIALKOXYPHOSPHINYL)METHYL PHOSPHATES AS ANTI-INFLAMMATORY AGENTS | THE UPJOHN COMPANY (US) | 1992-12-23 | — | — | WO | disclosed |
| EP-0014834-B1 | PROCESS FOR THE PREPARATION OF CARBON AMIDES AND OF PEPTIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220073547-A1 | Method of Preparing Phosphorus-Containing Flame Retardants and Their Use in Polymer Compositions | PPA1, PHOSPHO1, PFAS | PPARD 1128/4885FDPS 135/4885KDM4E 1587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.